IVIVR assessing PK parameters used to establish Bioequivalence

Trial Identifier: ALLO-101(QCL116986)
Sponsor: Ardea Biosciences, Inc.
Collaborator:
Quotient Clinical
Start Date: April 2015
Primary Completion Date: July 2015
Study Completion Date: September 2015
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United Kingdom Ruddington, United Kingdom, NG11 6JS